Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung

Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and clinical oncology 2018-05, Vol.144 (5), p.835-844
Hauptverfasser: Ueda, Takuya, Aokage, Keiju, Nishikawa, Hiroyoshi, Neri, Shinya, Nakamura, Hiroshi, Sugano, Masato, Tane, Kenta, Miyoshi, Tomohiro, Kojima, Motohiro, Fujii, Satoshi, Kuwata, Takeshi, Ochiai, Atsushi, Kusumoto, Masahiko, Suzuki, Kenji, Tsuboi, Masahiro, Ishii, Genichiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 844
container_issue 5
container_start_page 835
container_title Journal of cancer research and clinical oncology
container_volume 144
creator Ueda, Takuya
Aokage, Keiju
Nishikawa, Hiroyoshi
Neri, Shinya
Nakamura, Hiroshi
Sugano, Masato
Tane, Kenta
Miyoshi, Tomohiro
Kojima, Motohiro
Fujii, Satoshi
Kuwata, Takeshi
Ochiai, Atsushi
Kusumoto, Masahiko
Suzuki, Kenji
Tsuboi, Masahiro
Ishii, Genichiro
description Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Methods A total of 244 patients with p-stage I lung SqCC who underwent complete surgical resection were enrolled in this study. Clinicopathological differences between UIP-associated SqCC and non-UIP SqCC were examined. Moreover, we performed immunohistochemical studies to clarify the biological differences between these two groups. Results UIP-associated SqCC was detected in 19 patients (6.0%). Patients with UIP-associated SqCC tended to have shorter recurrence-free survival (RFS) (5-year RFS; UIP-associated SqCC 44% vs non-UIP SqCC 62%, p  = 0.05). Immunohistochemical analysis revealed that the expression scores of cancer stem cell- and invasion-related molecules in cancer cells were not significantly different between the two groups. However, PD-L1 expression in cancer cells was significantly higher in UIP-associated SqCC (median score; 5.0 vs 0, p  
doi_str_mv 10.1007/s00432-018-2602-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2001918179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2001918179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-eb8eb28266ba4653f35432886ef3ab569abf3940b7509eb020d99fb8f9f352cb3</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS1URC8XHoANssSmm4B_4iReoqqFSpXYwNqycyfFVWynnriIPj0Ot4CE1JU19jdnxucQ8oaz95yx_gMy1krRMD40omOieXhGdny74VKqE7JjvOeNErw7JS8Rb1mtVS9ekFOhW6l6qXbkx1UIJSYsy5IB0d8DXUtImQY_5gTx3ucUA8SVpokWLHamPq6QcfWrr8USoeLR28YiptHbFQ4U74oNqSAdYZ7paPPoYwp2k1i_A51LvHlFnk92Rnj9eO7Jt8uLr-efm-svn67OP143o-zF2oAbwIlBdJ2zbafkJFX93zB0MEnrVKetm6RumesV0-CYYAetJzdMupJidHJPzo66S053BXA1weO2lo1QNzSimqL5wHtd0Xf_obep5Fi3-00p1rLq2Z7wI1XtQcwwmSX7YPNPw5nZUjHHVExNxWypmIfa8_ZRubgAh78df2KogDgCWJ_iDeR_o59W_QWynZrz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2001504057</pqid></control><display><type>article</type><title>Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung</title><source>Springer Nature - Complete Springer Journals</source><creator>Ueda, Takuya ; Aokage, Keiju ; Nishikawa, Hiroyoshi ; Neri, Shinya ; Nakamura, Hiroshi ; Sugano, Masato ; Tane, Kenta ; Miyoshi, Tomohiro ; Kojima, Motohiro ; Fujii, Satoshi ; Kuwata, Takeshi ; Ochiai, Atsushi ; Kusumoto, Masahiko ; Suzuki, Kenji ; Tsuboi, Masahiro ; Ishii, Genichiro</creator><creatorcontrib>Ueda, Takuya ; Aokage, Keiju ; Nishikawa, Hiroyoshi ; Neri, Shinya ; Nakamura, Hiroshi ; Sugano, Masato ; Tane, Kenta ; Miyoshi, Tomohiro ; Kojima, Motohiro ; Fujii, Satoshi ; Kuwata, Takeshi ; Ochiai, Atsushi ; Kusumoto, Masahiko ; Suzuki, Kenji ; Tsuboi, Masahiro ; Ishii, Genichiro</creatorcontrib><description>Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Methods A total of 244 patients with p-stage I lung SqCC who underwent complete surgical resection were enrolled in this study. Clinicopathological differences between UIP-associated SqCC and non-UIP SqCC were examined. Moreover, we performed immunohistochemical studies to clarify the biological differences between these two groups. Results UIP-associated SqCC was detected in 19 patients (6.0%). Patients with UIP-associated SqCC tended to have shorter recurrence-free survival (RFS) (5-year RFS; UIP-associated SqCC 44% vs non-UIP SqCC 62%, p  = 0.05). Immunohistochemical analysis revealed that the expression scores of cancer stem cell- and invasion-related molecules in cancer cells were not significantly different between the two groups. However, PD-L1 expression in cancer cells was significantly higher in UIP-associated SqCC (median score; 5.0 vs 0, p  &lt; 0.01). In the stroma of UIP-associated SqCC, the number of Foxp3 + tumor-infiltrating lymphocytes was significantly higher than that in non-UIP SqCC (median number 43/HPF vs 24/HPF, p  &lt; 0.01). In addition, CD8 + /Foxp3 + T-cell ratio in UIP-associated SqCC was significantly lower than that in non-UIP SqCC (median ratio 1.8 vs 3.4, p  &lt; 0.01). Conclusion Our current study clearly revealed that the establishment of an immunosuppressive tumor microenvironment is a characteristic feature of UIP-associated SqCC, which can be correlated with poor prognosis in UIP-associated SqCC.</description><identifier>ISSN: 0171-5216</identifier><identifier>EISSN: 1432-1335</identifier><identifier>DOI: 10.1007/s00432-018-2602-z</identifier><identifier>PMID: 29435735</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer Research ; CD8 antigen ; Foxp3 protein ; Hematology ; Immunosuppression ; Internal Medicine ; Lung cancer ; Lung carcinoma ; Lymphocytes ; Lymphocytes T ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original Article – Cancer Research ; PD-L1 protein ; Pneumonia ; Squamous cell carcinoma ; Stem cells ; Stroma ; Tumor-infiltrating lymphocytes</subject><ispartof>Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.835-844</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-eb8eb28266ba4653f35432886ef3ab569abf3940b7509eb020d99fb8f9f352cb3</citedby><cites>FETCH-LOGICAL-c372t-eb8eb28266ba4653f35432886ef3ab569abf3940b7509eb020d99fb8f9f352cb3</cites><orcidid>0000-0001-8637-3323</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00432-018-2602-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00432-018-2602-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29435735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ueda, Takuya</creatorcontrib><creatorcontrib>Aokage, Keiju</creatorcontrib><creatorcontrib>Nishikawa, Hiroyoshi</creatorcontrib><creatorcontrib>Neri, Shinya</creatorcontrib><creatorcontrib>Nakamura, Hiroshi</creatorcontrib><creatorcontrib>Sugano, Masato</creatorcontrib><creatorcontrib>Tane, Kenta</creatorcontrib><creatorcontrib>Miyoshi, Tomohiro</creatorcontrib><creatorcontrib>Kojima, Motohiro</creatorcontrib><creatorcontrib>Fujii, Satoshi</creatorcontrib><creatorcontrib>Kuwata, Takeshi</creatorcontrib><creatorcontrib>Ochiai, Atsushi</creatorcontrib><creatorcontrib>Kusumoto, Masahiko</creatorcontrib><creatorcontrib>Suzuki, Kenji</creatorcontrib><creatorcontrib>Tsuboi, Masahiro</creatorcontrib><creatorcontrib>Ishii, Genichiro</creatorcontrib><title>Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung</title><title>Journal of cancer research and clinical oncology</title><addtitle>J Cancer Res Clin Oncol</addtitle><addtitle>J Cancer Res Clin Oncol</addtitle><description>Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Methods A total of 244 patients with p-stage I lung SqCC who underwent complete surgical resection were enrolled in this study. Clinicopathological differences between UIP-associated SqCC and non-UIP SqCC were examined. Moreover, we performed immunohistochemical studies to clarify the biological differences between these two groups. Results UIP-associated SqCC was detected in 19 patients (6.0%). Patients with UIP-associated SqCC tended to have shorter recurrence-free survival (RFS) (5-year RFS; UIP-associated SqCC 44% vs non-UIP SqCC 62%, p  = 0.05). Immunohistochemical analysis revealed that the expression scores of cancer stem cell- and invasion-related molecules in cancer cells were not significantly different between the two groups. However, PD-L1 expression in cancer cells was significantly higher in UIP-associated SqCC (median score; 5.0 vs 0, p  &lt; 0.01). In the stroma of UIP-associated SqCC, the number of Foxp3 + tumor-infiltrating lymphocytes was significantly higher than that in non-UIP SqCC (median number 43/HPF vs 24/HPF, p  &lt; 0.01). In addition, CD8 + /Foxp3 + T-cell ratio in UIP-associated SqCC was significantly lower than that in non-UIP SqCC (median ratio 1.8 vs 3.4, p  &lt; 0.01). Conclusion Our current study clearly revealed that the establishment of an immunosuppressive tumor microenvironment is a characteristic feature of UIP-associated SqCC, which can be correlated with poor prognosis in UIP-associated SqCC.</description><subject>Cancer Research</subject><subject>CD8 antigen</subject><subject>Foxp3 protein</subject><subject>Hematology</subject><subject>Immunosuppression</subject><subject>Internal Medicine</subject><subject>Lung cancer</subject><subject>Lung carcinoma</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original Article – Cancer Research</subject><subject>PD-L1 protein</subject><subject>Pneumonia</subject><subject>Squamous cell carcinoma</subject><subject>Stem cells</subject><subject>Stroma</subject><subject>Tumor-infiltrating lymphocytes</subject><issn>0171-5216</issn><issn>1432-1335</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kc1u1TAQhS1URC8XHoANssSmm4B_4iReoqqFSpXYwNqycyfFVWynnriIPj0Ot4CE1JU19jdnxucQ8oaz95yx_gMy1krRMD40omOieXhGdny74VKqE7JjvOeNErw7JS8Rb1mtVS9ekFOhW6l6qXbkx1UIJSYsy5IB0d8DXUtImQY_5gTx3ucUA8SVpokWLHamPq6QcfWrr8USoeLR28YiptHbFQ4U74oNqSAdYZ7paPPoYwp2k1i_A51LvHlFnk92Rnj9eO7Jt8uLr-efm-svn67OP143o-zF2oAbwIlBdJ2zbafkJFX93zB0MEnrVKetm6RumesV0-CYYAetJzdMupJidHJPzo66S053BXA1weO2lo1QNzSimqL5wHtd0Xf_obep5Fi3-00p1rLq2Z7wI1XtQcwwmSX7YPNPw5nZUjHHVExNxWypmIfa8_ZRubgAh78df2KogDgCWJ_iDeR_o59W_QWynZrz</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Ueda, Takuya</creator><creator>Aokage, Keiju</creator><creator>Nishikawa, Hiroyoshi</creator><creator>Neri, Shinya</creator><creator>Nakamura, Hiroshi</creator><creator>Sugano, Masato</creator><creator>Tane, Kenta</creator><creator>Miyoshi, Tomohiro</creator><creator>Kojima, Motohiro</creator><creator>Fujii, Satoshi</creator><creator>Kuwata, Takeshi</creator><creator>Ochiai, Atsushi</creator><creator>Kusumoto, Masahiko</creator><creator>Suzuki, Kenji</creator><creator>Tsuboi, Masahiro</creator><creator>Ishii, Genichiro</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8637-3323</orcidid></search><sort><creationdate>20180501</creationdate><title>Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung</title><author>Ueda, Takuya ; Aokage, Keiju ; Nishikawa, Hiroyoshi ; Neri, Shinya ; Nakamura, Hiroshi ; Sugano, Masato ; Tane, Kenta ; Miyoshi, Tomohiro ; Kojima, Motohiro ; Fujii, Satoshi ; Kuwata, Takeshi ; Ochiai, Atsushi ; Kusumoto, Masahiko ; Suzuki, Kenji ; Tsuboi, Masahiro ; Ishii, Genichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-eb8eb28266ba4653f35432886ef3ab569abf3940b7509eb020d99fb8f9f352cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer Research</topic><topic>CD8 antigen</topic><topic>Foxp3 protein</topic><topic>Hematology</topic><topic>Immunosuppression</topic><topic>Internal Medicine</topic><topic>Lung cancer</topic><topic>Lung carcinoma</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original Article – Cancer Research</topic><topic>PD-L1 protein</topic><topic>Pneumonia</topic><topic>Squamous cell carcinoma</topic><topic>Stem cells</topic><topic>Stroma</topic><topic>Tumor-infiltrating lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ueda, Takuya</creatorcontrib><creatorcontrib>Aokage, Keiju</creatorcontrib><creatorcontrib>Nishikawa, Hiroyoshi</creatorcontrib><creatorcontrib>Neri, Shinya</creatorcontrib><creatorcontrib>Nakamura, Hiroshi</creatorcontrib><creatorcontrib>Sugano, Masato</creatorcontrib><creatorcontrib>Tane, Kenta</creatorcontrib><creatorcontrib>Miyoshi, Tomohiro</creatorcontrib><creatorcontrib>Kojima, Motohiro</creatorcontrib><creatorcontrib>Fujii, Satoshi</creatorcontrib><creatorcontrib>Kuwata, Takeshi</creatorcontrib><creatorcontrib>Ochiai, Atsushi</creatorcontrib><creatorcontrib>Kusumoto, Masahiko</creatorcontrib><creatorcontrib>Suzuki, Kenji</creatorcontrib><creatorcontrib>Tsuboi, Masahiro</creatorcontrib><creatorcontrib>Ishii, Genichiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ueda, Takuya</au><au>Aokage, Keiju</au><au>Nishikawa, Hiroyoshi</au><au>Neri, Shinya</au><au>Nakamura, Hiroshi</au><au>Sugano, Masato</au><au>Tane, Kenta</au><au>Miyoshi, Tomohiro</au><au>Kojima, Motohiro</au><au>Fujii, Satoshi</au><au>Kuwata, Takeshi</au><au>Ochiai, Atsushi</au><au>Kusumoto, Masahiko</au><au>Suzuki, Kenji</au><au>Tsuboi, Masahiro</au><au>Ishii, Genichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung</atitle><jtitle>Journal of cancer research and clinical oncology</jtitle><stitle>J Cancer Res Clin Oncol</stitle><addtitle>J Cancer Res Clin Oncol</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>144</volume><issue>5</issue><spage>835</spage><epage>844</epage><pages>835-844</pages><issn>0171-5216</issn><eissn>1432-1335</eissn><abstract>Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Methods A total of 244 patients with p-stage I lung SqCC who underwent complete surgical resection were enrolled in this study. Clinicopathological differences between UIP-associated SqCC and non-UIP SqCC were examined. Moreover, we performed immunohistochemical studies to clarify the biological differences between these two groups. Results UIP-associated SqCC was detected in 19 patients (6.0%). Patients with UIP-associated SqCC tended to have shorter recurrence-free survival (RFS) (5-year RFS; UIP-associated SqCC 44% vs non-UIP SqCC 62%, p  = 0.05). Immunohistochemical analysis revealed that the expression scores of cancer stem cell- and invasion-related molecules in cancer cells were not significantly different between the two groups. However, PD-L1 expression in cancer cells was significantly higher in UIP-associated SqCC (median score; 5.0 vs 0, p  &lt; 0.01). In the stroma of UIP-associated SqCC, the number of Foxp3 + tumor-infiltrating lymphocytes was significantly higher than that in non-UIP SqCC (median number 43/HPF vs 24/HPF, p  &lt; 0.01). In addition, CD8 + /Foxp3 + T-cell ratio in UIP-associated SqCC was significantly lower than that in non-UIP SqCC (median ratio 1.8 vs 3.4, p  &lt; 0.01). Conclusion Our current study clearly revealed that the establishment of an immunosuppressive tumor microenvironment is a characteristic feature of UIP-associated SqCC, which can be correlated with poor prognosis in UIP-associated SqCC.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29435735</pmid><doi>10.1007/s00432-018-2602-z</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-8637-3323</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0171-5216
ispartof Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.835-844
issn 0171-5216
1432-1335
language eng
recordid cdi_proquest_miscellaneous_2001918179
source Springer Nature - Complete Springer Journals
subjects Cancer Research
CD8 antigen
Foxp3 protein
Hematology
Immunosuppression
Internal Medicine
Lung cancer
Lung carcinoma
Lymphocytes
Lymphocytes T
Medical prognosis
Medicine
Medicine & Public Health
Oncology
Original Article – Cancer Research
PD-L1 protein
Pneumonia
Squamous cell carcinoma
Stem cells
Stroma
Tumor-infiltrating lymphocytes
title Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A52%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunosuppressive%20tumor%20microenvironment%20of%20usual%20interstitial%20pneumonia-associated%20squamous%20cell%20carcinoma%20of%20the%20lung&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.au=Ueda,%20Takuya&rft.date=2018-05-01&rft.volume=144&rft.issue=5&rft.spage=835&rft.epage=844&rft.pages=835-844&rft.issn=0171-5216&rft.eissn=1432-1335&rft_id=info:doi/10.1007/s00432-018-2602-z&rft_dat=%3Cproquest_cross%3E2001918179%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2001504057&rft_id=info:pmid/29435735&rfr_iscdi=true